$27.180
+0.802 (+2.95%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Lycia Therapeutics, Inc. Common Stock Stock?
Lycia Therapeutics, Inc. is currently trading at $27.18, which is 49.6% of its 52-week range. While the stock has shown a strong year-to-date increase of 51%, it has recently declined by 5.79% over the past five days. The lack of a P/E ratio and high price-to-sales ratio of 310.1 indicate potential overvaluation concerns. The main risk is the recent decline in IPO activity, which may affect market sentiment and investor confidence.
LYCA stock price ended at $27.18 on Monday, after rising +2.95%
Lycia Therapeutics, Inc. Common Stock (LYCA) last closed at $27.1800003, gaining +2.95%. These facts feed the 1-day and 1-week LYCA price prediction above.
Forecast Drivers
Lycia Therapeutics, Inc. Common Stock (LYCA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
Seasonality analysis for LYCA
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.